Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.53B | 1.45B | 1.40B | 2.69B | 3.70B | Gross Profit |
1.53B | 1.40B | 1.31B | 2.54B | 3.60B | EBIT |
351.00M | -282.00M | -598.00M | 1.11B | 738.00M | EBITDA |
0.00 | 0.00 | -420.00M | 1.31B | 872.00M | Net Income Common Stockholders |
248.00M | 1.00M | -549.00M | 994.00M | 833.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.33B | 1.20B | 1.16B | 1.94B | 1.52B | Total Assets |
7.72B | 8.03B | 9.25B | 11.42B | 10.48B | Total Debt |
597.00M | 1.03B | 624.00M | 706.00M | 840.00M | Net Debt |
-738.00M | -167.00M | -532.00M | -1.23B | -717.00M | Total Liabilities |
2.68B | 3.15B | 3.37B | 706.00M | 3.67B | Stockholders Equity |
5.03B | 4.88B | 5.87B | 7.85B | 6.81B |
Cash Flow | Free Cash Flow | |||
180.00M | 162.00M | 83.00M | 2.00M | 31.00M | Operating Cash Flow |
213.00M | 221.00M | 110.00M | 14.00M | 56.00M | Investing Cash Flow |
258.00M | 542.00M | -86.00M | 755.00M | 1.01B | Financing Cash Flow |
-342.00M | -711.00M | -761.00M | -243.00M | -1.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £5.72B | 13.97 | 9.48% | 5.82% | 0.72% | 7.66% | |
77 Outperform | £2.01B | 8.80 | 17.94% | 7.32% | 18.85% | 26.14% | |
77 Outperform | £1.72B | 25.94 | 4.83% | 5.68% | 49.59% | 18.13% | |
64 Neutral | $12.85B | 9.81 | 7.59% | 16985.65% | 12.30% | -7.71% | |
63 Neutral | £3.27B | 13.90 | 4.88% | 7.96% | -5.51% | 1596.15% | |
$7.81B | 31.80 | -10.00% | 7.89% | ― | ― | ||
$4.13B | 8.22 | 40.46% | 8.30% | ― | ― |